MBL

Anti-GST-P (Rat) pAb

Product Code:
 
MBL-311
Product Group:
 
Primary Antibodies
Supplier:
 
MBL
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
  • Human
  • Rat
Applications:
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
 
4°C
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
MBL-311100 ul£296.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Alternative Names:
GSTP1 glutathione S-transferase pi 1, PI, DFN7, GST3, GSTP, FAEES3
Applications:
WB - 1:1000-1:2000 (chemiluminescence detection system) IHC - 1:1000-1:2000 (frozen sections, paraffin sections)
Background:
Placental gultathione S-transferase (GST-P), a member of glutathione S-transferase, is known for its specific expression during rat hepatocarcinogenessis and has been used as a reliable tumor marker for experimental rat hepatocarcinogenesis
Formulation:
100 ug (0.5 mg/ml) affinity purified rabbit anti-p53 polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 30% glycerol, 0.5% BSA, 0.01% thimerosal.
Gene IDs:
Human: 2950 Mouse: 14870 Rat: 24426
Immunogen Translated:
Purified rat liver glutathione S-transferase P
Reactivity:
This antibody reacts with glutathione S-transferase P (27 kDa) on Western blotting.
Shelf Life:
1 year
Source:
This antibody was purified from rabbit serum using protein A agarose. The rabbit was immunized with purified rat liver glutathione S-transferase P.
Target:
GST-pi

Documents

References

1) Suzuki, R., et al., Carcinogenesis 27, 619-630 (2006) 2) Ueno, S., et al., Clin. Cancer Res. 11, 5645-5650 (2005) 3) Hasumura, M., et al., Toxicol. Sci. 86, 61-67 (2005) 4) Sukata, T., et al., Am. J. Pathol. 165,1479-1488 (2004) 5) Suzuki, S., et al., Carcinogenesis 25, 439-443 (2004) 6) Nakaji, M., et al., Carcinogenesis 25, 389-397 (2004) 7) Oyama, K., et al., Carcinogenesis 23, 885-892 (2002) 8) Denda, A., et al., Carcinogenesis 23, 245-256 (2002) 9) Yan, Y., et al., Carcinogenesis 23, 189-196 (2002) 10) Zeng, Z-Z., et al., Cancer Res. 60, 2876-2881 (2000) 11) Ledda-Columbano, G. M., et al., Carcinogenesis 20, 2299-2304 (1999) 12) Kobayashi, Y., et al., Carcinogenesis 19, 1809-1814 (1998) 13) Denda, A., et al., Carcinogenesis 18, 1921-1930 (1997) 14) Endoh, T., et al., Carcinogenesis 17, 467-475 (1996) 15) Sato, K., et al., PNAS 82, 3964-3968 (1985)